The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(E)-4-(N-(2-(1-(Hydroxyimino)ethyl)phenyl)sulfamoyl)phenyl pivalate ID: ALA3398148
PubChem CID: 118202507
Max Phase: Preclinical
Molecular Formula: C19H22N2O5S
Molecular Weight: 390.46
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: C/C(=N/O)c1ccccc1NS(=O)(=O)c1ccc(OC(=O)C(C)(C)C)cc1
Standard InChI: InChI=1S/C19H22N2O5S/c1-13(20-23)16-7-5-6-8-17(16)21-27(24,25)15-11-9-14(10-12-15)26-18(22)19(2,3)4/h5-12,21,23H,1-4H3/b20-13-
Standard InChI Key: MSIGLHAWDSGRGI-MOSHPQCFSA-N
Molfile:
RDKit 2D
27 28 0 0 0 0 0 0 0 0999 V2000
2.5951 -3.0039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8933 -3.7570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8916 -4.9570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9336 -3.1588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9316 -4.3586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5548 -3.6021 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5973 -1.5031 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5988 1.5004 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-3.6378 0.9001 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.5998 3.0012 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.8995 3.7516 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9027 5.2517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2032 5.9990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.5007 5.2464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4977 3.7464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1971 2.9990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6060 6.0074 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6113 7.5083 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.5645 5.4114 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6383 2.0999 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.6522 8.1053 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
2 4 1 0
2 5 1 0
1 6 2 0
1 7 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
8 13 2 0
14 15 2 0
14 16 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
17 22 2 0
23 24 2 0
23 25 1 0
18 23 1 0
16 17 1 0
11 14 1 0
7 8 1 0
14 26 2 0
24 27 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 390.46Molecular Weight (Monoisotopic): 390.1249AlogP: 3.64#Rotatable Bonds: 5Polar Surface Area: 105.06Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 6.52CX Basic pKa: 1.39CX LogP: 3.43CX LogD: 2.08Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.27Np Likeness Score: -1.12
References 1. Hwang TL, Wang WH, Wang TY, Yu HP, Hsieh PW.. (2015) Synthesis and pharmacological characterization of 2-aminobenzaldehyde oxime analogs as dual inhibitors of neutrophil elastase and proteinase 3., 23 (5): [PMID:25650311 ] [10.1016/j.bmc.2014.12.056 ]